APPLICATION OF THERAPEUTIC HUMAN ALBUMIN FOR THE PRODUCTION OF A MEDICINE FOR THE TREATMENT OF PATIENTS AFFECTING COGNITIVE DISORDERS

摘要

1. The use of human albumin for the manufacture of a medicament for the treatment of patients suffering from cognitive disorders or at risk of their development, regardless of the content of Aβ in the blood of the patient. ! 2. The use according to claim 1, wherein the drug is in the form of a plasma filtration solution. ! 3. The use according to claim 1, in which this drug is in the form of a solution for intravenous use. ! 4. The use according to claim 1, wherein the albumin initially has a concentration of from 4% (w / v) to 25% (w / v). ! 5. The use according to claim 4, in which the used albumin has a concentration of from 4.5% (wt./about.) To 5.5% (wt./about.). ! 6. The use according to claim 1, in which the used albumin has better binding ability compared to a therapeutic albumin preparation made in accordance with the European Pharmacopoeia. ! 7. The use according to any one of claims 1 to 6, in which the cognitive disorder is Alzheimer's disease.